Evergreen Capital Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$233K Buy
+790
New +$208K ﹤0.01% 1313
2026
Q2
– Sell
-1,430
Closed -$247K – 1565
2026
Q1
$247K Buy
+1,430
New +$265K 0.01% 1262
2025
Q2
– Sell
-1,738
Closed -$262K – 1162
2025
Q1
$262K Buy
+1,738
New +$291K 0.01% 834

Other funds holding CRL

Evergreen Capital Management's CRL Position: Q3 2026 in Review

Evergreen Capital Management opened a new position in Charles River Laboratories (CRL) in Q3 2026: 790 shares worth $233K. The stake represents ﹤0.01% of the portfolio and ranks #1313 among its holdings. This is a return to the name: Evergreen Capital Management previously reported a position in CRL as recently as Q1 2026.

Evergreen Capital Management first reported a position in CRL in Q1 2025 and has held it in 3 quarters since. The position peaked at $262K in Q1 2025. 646 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • Evergreen Capital Management held 790 shares of Charles River Laboratories worth $233K as of Q3 2026.
  • Charles River Laboratories was a new Evergreen Capital Management position in Q3 2026.
  • Charles River Laboratories made up ﹤0.01% of Evergreen Capital Management's portfolio in Q3 2026, its #1313 holding.
  • Evergreen Capital Management first reported a position in Charles River Laboratories in Q1 2025 and has held it in 3 quarters since.
  • Evergreen Capital Management's Charles River Laboratories position peaked at $262K in Q1 2025.
  • 646 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on Evergreen Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.